.0,7304008.0,2017-03-08 14:08:16,Worldwide,,Tuberculosis,Humans,?id=20170308.4887127,PRO/ALL> New in IJID (03): March 2017. TB issue,"NEW IN THE INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (03): MARCH 2017. TB ISSUE**********************************************************************************A ProMED-mail post<http://www.promedmail.org>ProMED-mail is a program of theInternational Society for Infectious Diseases<http://www.isid.org>Special issue: commemorating World Tuberculosis Day [24 Mar 2017]-----------------------------------------------------------------Editorial---------World TB Day 2017: advances, challenges and opportunities in the ""end-TB"" era.Eskild Petersen, Markus Maeurer, Ben Marais, et al.Int J Infect Dis. 2017; 56: 1-5; pii: S1201-9712(17)30059-0. doi: 10.1016/j.ijid.2017.02.012<http://www.ijidonline.com/article/S1201-9712(17)30059-0/fulltext>Reviews-------The risk of global epidemic replacement with drug-resistant _Mycobacterium tuberculosis_ strains.Emma S McBryde, Michael T Meehan, Tan N Doan, et al.Int J Infect Dis. 2017; 56: 14-20; pii: S1201-9712(17)30034-6. doi: 10.1016/j.ijid.2017.01.031<http://www.ijidonline.com/article/S1201-9712(17)30034-6/fulltext>Less research on tuberculosis than HIV and malaria when research agendas are poorly coordinated: a systematic review of research outputs from Cambodia.Mishal Khan, Richard James, Neisha Sundaram, et al.Int J Infect Dis. 2017; 56: 25-29; doi: 10.1016/j.ijid.2016.11.417<http://www.ijidonline.com/article/S1201-9712(16)31636-8/fulltext>De-isolation of patients with pulmonary tuberculosis after start of treatment -- clear, unequivocal guidelines are missing.Eskild Petersen, Faryal Khamis, Giovanni Battista Migliori, et al.Int J Infect Dis. 2017; 56; 34-38; doi: 10.1016/j.ijid.2017.01.029<http://www.ijidonline.com/article/S1201-9712(17)30032-2/fulltext>Tuberculosis associated mortality in a prospective cohort in Sub Saharan Africa: association with HIV and antiretroviral therapy.Tumaini J Nagu, Said Aboud, Ramadhani Mwiru, et al.Int J Infect Dis. 2017; 56: 39-44; doi: 10.1016/j.ijid.2017.01.023<http://www.ijidonline.com/article/S1201-9712(17)30026-7/fulltext>The global dynamics of diabetes and tuberculosis: the impact of migration and policy implications.Enrico Girardi, Monica SaÌ±Ì© Schepisi, Delia Goletti, et al.Int J Infect Dis. 2017; 56: 45-53; doi: 10.1016/j.ijid.2017.01.018<http://www.ijidonline.com/article/S1201-9712(17)30021-8/fulltext>Tuberculosis and hypertension -- a systematic review of the literature.Anneline Borchsenius Seegert, Frauke Rudolf, Christian Wejse, et al.Int J Infect Dis. 2017; 56: 54-61; doi: 10.1016/j.ijid.2016.12.016<http://www.ijidonline.com/article/S1201-9712(16)31659-9/fulltext>Preventive therapy for latent tuberculosis infection -- the promise and the challenges.GJ Fox, CC Dobler, BJ Marais, et al.Int J Infect Dis. 2017; 56: 68-76; doi: 10.1016/j.ijid.2016.11.006<http://www.ijidonline.com/article/S1201-9712(16)31223-1/fulltext>Tuberculosis stigma as a social determinant of health: a systematic mapping review of research in low incidence countries.GM Craig, A Daftary, N Engel, et al.Int J Infect Dis. 2017; 56: 90-100; doi: 10.1016/j.ijid.2016.10.011<http://www.ijidonline.com/article/S1201-9712(16)31622-8/fulltext>Evaluating the impact of healthcare provider training to improve tuberculosis management: a systematic review of methods and outcome indicators used.Shishi Wu, Imara Roychowdhury, Mishal KhanInt J Infect Dis. 2017; 56: 105-110; doi: 10.1016/j.ijid.2016.11.421<http://www.ijidonline.com/article/S1201-9712(16)31194-8/fulltext>Quality of tuberculosis care in high burden countries: the urgent need to address gaps in the care cascade.Danielle Cazabon, Hannah Alsdurf, Srinath Satyanarayana, et al.Int J Infect Dis. 2017; 56: 111-116; doi: 10.1016/j.ijid.2016.10.016<http://www.ijidonline.com/article/S1201-9712(16)31641-1/fulltext>Status of tuberculosis services in Indian prisons.Banuru Muralidhara Prasad, Badri Thapa, Sarabjit Singh Chadha, et al.Int J Infect Dis. 2017; 56: 117-121; doi: 10.1016/j.ijid.2017.01.035<http://www.ijidonline.com/article/S1201-9712(16)31200-0/fulltext>Improving access to tuberculosis preventive therapy and treatment for children.Ben J Marais.Int J Infect Dis. 2017; 56: 122-125; doi: 10.1016/j.ijid.2016.12.015<http://www.ijidonline.com/article/S1201-9712(17)30038-3/fulltext>Learning from epidemiological, clinical, and immunological studies on _Mycobacterium africanum_ for improving current understanding of host-pathogen interactions, and for the development and evaluation of diagnostics, host-directed therapies, and vaccines for tuberculosis.Alimuddin Zumla, Isaac Darko Otchere, Gloria Ivy Mensah, et al.Int J Infect Dis. 2017; 56: 126-129; doi: 10.1016/j.ijid.2016.12.003<http://www.ijidonline.com/article/S1201-9712(16)31658-7/fulltext>Removing the bottleneck in whole genome sequencing of _Mycobacterium tuberculosis_ for rapid drug resistance analysis: a call to action.Ruth McNerney, Taane G Clark, Susana Campino, et al.Int J Infect Dis. 2017; 56: 130-135; doi: 10.1016/j.ijid.2016.11.422<http://www.ijidonline.com/article/S1201-9712(16)31646-0/fulltext>Strong anti-Epstein Barr virus (EBV) or cytomegalovirus (CMV) cellular immune responses predict survival and a favourable response to anti-tuberculosis therapy.Tumaini Nagu, Said Aboud, Martin Rao, et al.Int J Infect Dis. 2017; 56: 136-139; doi: 10.1016/j.ijid.2017.01.022<http://www.ijidonline.com/article/S1201-9712(16)31642-3/fulltext>Peptide microarray-based characterization of antibody responses to host proteins after bacille Calmette-GuÌ©rin vaccination.Davide Valentini, Martin Rao, Lalit Rane, et al.Int J Infect Dis. 2017; 56: 140-154; doi: 10.1016/j.ijid.2017.01.027<http://www.ijidonline.com/article/S1201-9712(16)31642-3/fulltext>Immune recognition surface construction of Mycobacterium tuberculosis epitope-specific antibody responses in tuberculosis patients identified by peptide microarrays.Davide Valentini, Martin Rao, Giovanni Ferrara, et al.Int J Infect Dis. 2017; 56: 155-166; doi: 10.1016/j.ijid.2017.01.015<http://www.ijidonline.com/article/S1201-9712(17)30030-9/fulltext>Humoral immune profiling of mycobacterial antigen recognition in sarcoidosis and LÌ¦fgren's syndrome using high-content peptide microarrays.Giovanni Ferrara, Davide Valentini, Martin Rao, et al.Int J Infect Dis. 2017; 56: 167-175; doi: 10.1016/j.ijid.2017.01.021<http://www.ijidonline.com/article/S1201-9712(17)30024-3/fulltext>Insights gained from ancient biomolecules into past and present tuberculosis -- a personal perspective.Helen D Donoghue.Int J Infect Dis. 2017; 56: 176-180; doi: 10.1016/j.ijid.2016.11.413<http://www.ijidonline.com/article/S1201-9712(17)30024-3/fulltext>Second line drug susceptibility testing to inform the treatment of rifampin-resistant tuberculosis: a quantitative perspective.Emily A Kendall, Ted Cohen, Carole D Mitnick, et al.Int J Infect Dis. 2017; 56: 185-189; doi: 10.1016/j.ijid.2016.12.010<http://www.ijidonline.com/article/S1201-9712(16)31210-3/fulltext>Pediatric multidrug-resistant tuberculosis clinical trials: challenges and opportunities.SE McAnaw, AC Hesseling, JA Seddon, et al.Int J Infect Dis. 2017; 56: 194-199; doi: 10.1016/j.ijid.2016.11.423<http://www.ijidonline.com/article/S1201-9712(16)31643-5/fulltext>Retrospective study of clinical and lesion characteristics of patients undergoing surgical treatment for pulmonary tuberculosis in Georgia.Sergo Vashakidze, Albert Despuig, Shota Gogishvili, et al.Int J Infect Dis. 2017; 56: 200-207; doi: 10.1016/j.ijid.2016.12.009<http://www.ijidonline.com/article/S1201-9712(16)31652-6/fulltext>New tuberculosis drug leads from naturally occurring compounds.Diana Quan, Gayathri Nagalingam, Richard Payne, et al.Int J Infect Dis. 2017; 56: 212-220; doi: 10.1016/j.ijid.2016.12.024<http://www.ijidonline.com/article/S1201-9712(16)31669-1/fulltext>Anti-PD-1/PD-L1 therapy for infectious diseases: learning from the cancer paradigm.Martin Rao, Davide Valentini, Ernest Dodoo, et al.Int J Infect Dis. 2017; 56: 221-228; doi: 10.1016/j.ijid.2017.01.028<http://www.ijidonline.com/article/S1201-9712(17)30031-0/fulltext>Ultrasound for patients in a high HIV/tuberculosis prevalence setting: a needs assessment and review of focused applications for Sub-Saharan Africa.Tom Heller, Eric A Mtemang'ombe, MichaÌÇla AM Huson, et al.Int J Infect Dis. 2017; 56: 229-236; doi: 10.1016/j.ijid.2016.11.001<http://www.ijidonline.com/article/S1201-9712(16)31216-4/fulltext>Imaging in extrapulmonary tuberculosis.Sanjay Gambhir, Mudalsha Ravina, Kasturi Rangan, et al.Int J Infect Dis. 2017; 56: 237-247; doi: 10.1016/j.ijid.2016.11.003<http://www.ijidonline.com/article/S1201-9712(16)31220-6/fulltext>Exploring tuberculosis by molecular tests on DNA isolated from smear microscopy slides.Niaina Rakotosamimanana, Marie Sylvianne Rabodoarivelo, Juan Carlos Palomino, et al.Int J Infect Dis. 2017; 56: 248-252; doi: 10.1016/j.ijid.2016.12.005<http://www.ijidonline.com/article/S1201-9712(16)31648-4/fulltext>A tuberculosis biomarker database: the key to novel TB diagnostics.Seda Yerlikaya, Tobias Broger, Emily MacLean, et al.Int J Infect Dis. 2017; 56: 253-257; doi: 10.1016/j.ijid.2017.01.025<http://www.ijidonline.com/article/S1201-9712(17)30028-0/fulltext>High-throughput and computational approaches for diagnostic and prognostic host tuberculosis biomarkers.January Weiner, Stefan HE Kaufmann.Int J Infect Dis. 2017; 56: 258-262; doi: 10.1016/j.ijid.2016.10.017<http://www.ijidonline.com/article/S1201-9712(16)31201-2/fulltext>Novel approaches to tuberculosis vaccine development.Stefan HE Kaufmann, January Weiner, C Fordham von Reyn.Int J Infect Dis. 2017; 56: 263-267; doi: 10.1016/j.ijid.2016.10.018<http://www.ijidonline.com/article/S1201-9712(16)31202-4/fulltext>Experimental animal modelling for TB vaccine development.Pere-Joan Cardona, Ann Williams.Int J Infect Dis. 2017; 56: 268-273; doi: 10.1016/j.ijid.2017.01.030<http://www.ijidonline.com/article/S1201-9712(17)30033-4/fulltext>_Mycobacterium tuberculosis_ proteins involved in cell wall lipid biosynthesis improve BCG vaccine efficacy in a murine TB model.Martin Rao, Nathalie Cadieux, Megan Fitzpatrick, et al.Int J Infect Dis. 2017; 56: 274-282; doi: 10.1016/j.ijid.2017.01.024<http://www.ijidonline.com/article/S1201-9712(17)30027-9/fulltext>A literary approach to tuberculosis: lessons learned from Anton Chekhov, Franz Kafka, and Katherine Mansfield.Cristina Vilaplana.Int J Infect Dis. 2017; 56: 283-285; doi: 10.1016/j.ijid.2016.12.012<http://www.ijidonline.com/article/S1201-9712(16)31655-1/fulltext>Original reports----------------Turning the tide against tuberculosis, International Journal of Infectious Diseases.Nesri Padayatchi, Naressa Naidu, Gerald Friedland, et al.Int J Infect Dis. 2017; 56: 6-9; doi: 10.1016/j.ijid.2017.01.012<http://www.ijidonline.com/article/S1201-9712(17)30015-2/fulltext>Tuberculosis eradication versus control.Marco Schito, Debra Hanna, Alimuddin Zumla.Int J Infect Dis. 2017; 56: 10-13; doi: 10.1016/j.ijid.2016.11.007<http://www.ijidonline.com/article/S1201-9712(16)31224-3/fulltext>Funding for tuberculosis research--an urgent crisis of political will, human rights, and global solidarity.Mike Frick.Int J Infect Dis. 2017; 56: 21-24; doi: 10.1016/j.ijid.2016.11.412<http://www.ijidonline.com/article/S1201-9712(16)31630-7/fulltext>Shifting from tuberculosis control to elimination: where are we? What are the variables and limitations? Is it achievable?Rosella Centis, Lia D'Ambrosio, Alimuddin Zumla, et al.Int J Infect Dis. 2017; 56: 30-33; doi: 10.1016/j.ijid.2016.11.416<http://www.ijidonline.com/article/S1201-9712(16)31635-6/fulltext>Health systems in the Republic of Congo: challenges and opportunities for implementing tuberculosis and HIV collaborative service, research, and training activities.Laure Stella Ghoma Linguissi, Luc Christian Gwom, Celine Nguefeu Nkenfou, et al.Int J Infect Dis. 2017; 56: 62-67; doi: 10.1016/j.ijid.2016.10.012<http://www.ijidonline.com/article/S1201-9712(16)31196-1/fulltext>European policies in the management of tuberculosis among migrants.Lia D'Ambrosio, Rosella Centis, Masoud Dara, et al.Int J Infect Dis. 2017; 56: 85-89; doi: 10.1016/j.ijid.2016.11.002<http://www.ijidonline.com/article/S1201-9712(16)31622-8/fulltext>Impact of infectious disease epidemics on tuberculosis diagnostic, management, and prevention services: experiences and lessons from the 2014-2015 Ebola virus disease outbreak in West Africa.Rashid Ansumana, Samuel Keitell, Gregory MT Roberts, et al.Int J Infect Dis. 2017; 56: 101-104; doi: 10.1016/j.ijid.2016.10.010<http://www.ijidonline.com/article/S1201-9712(16)31195-X/fulltext>Classifying new anti-tuberculosis drugs: rationale and future perspectives.Simon Tiberi, Anna Scardigli, Rosella Centis, et al.Int J Infect Dis. 2017; 56: 181-184; doi: 10.1016/j.ijid.2016.10.026<http://www.ijidonline.com/article/S1201-9712(16)31631-9/fulltext>Applicability of the shorter 'Bangladesh regimen' in high multidrug-resistant tuberculosis settings.Giovanni Sotgiu, Simon Tiberi, Rosella Centis, et al.Int J Infect Dis. 2017; 56: 190-193; doi: 10.1016/j.ijid.2016.10.021<http://www.ijidonline.com/article/S1201-9712(16)31653-8/fulltext>Advancing tuberculosis drug regimen development through innovative quantitative translational pharmacology methods and approaches.Debra Hanna, Klaus Romero, Marco Schito.Int J Infect Dis. 2017; 56: 208-211; doi: 10.1016/j.ijid.2016.10.008<http://www.ijidonline.com/article/S1201-9712(16)31191-2/fulltext>Perspectives------------Tackling TB in low-incidence countries: improving diagnosis and management in vulnerable populations.CC Heuvelings, SG de Vries, MP Grobusch.Int J Infect Dis. 2017; 56: 77-80; doi: 10.1016/j.ijid.2016.12.025<http://www.ijidonline.com/article/S1201-9712(16)31223-1/fulltext>Enhanced laboratory capacity development: a boost for effective tuberculosis control in resource-limited settings.Abraham Sunday Alabi, Afsatou Ndama TraorÌ©, Marguerite Massinga Loembe, et al.Int J Infect Dis. 2017; 56: 81-84; doi: 10.1016/j.ijid.2016.11.404<http://www.ijidonline.com/article/S1201-9712(16)31670-8/fulltext>--communicated by:ProMED-mail<promed@promedmail.org>[This issue of the IJID is devoted entirely to tuberculosis to mark World Tuberculosis Day on 24 Mar 2017. TB continues to be a formidable global health threat and, as documented in the special issue, the obstacles are many and TB funding for research into control and management lags behind funding for HIV and malaria. - Mod.EP][See Also:New in IJID (02): February 2017 20170221.4854153New in IJID (01): January 2017 20170106.47459332016---New in IJID (06): November 2016 20161120.4641660New in IJID (05): October 2016 20161024.4581350New in IJID (04): September 2016 20161005.4538286New in IJID (03): August 2016 20160805.4396893New in IJID (02): June 2016. Special issue on mass gathering medicine 20160729.4379342New in IJID (01): March 2016 20160305.4069475].................................................ep/mj/sh"
